CLINICAL PROGRAM
| Study Name | Type of Study | Total Patients | Status | Links | |||
|---|---|---|---|---|---|---|---|
| Vascular Intervention | |||||||
| BioMime Sirolimus Eluting Coronary Stent System | |||||||
| Sponsor Initiated Studies | |||||||
| meriT- 1 Study | First-in-man | 30 | Completed | Know more | |||
| meriT-2 Study | Observational study | 250 | Completed | Know more | |||
| meriT-3 Study | Observational study | 1161 | Completed | Know more | |||
| meriT-V Study | Randomized controlled trial | 256 | Ongoing | Know more | |||
| MILES-UK Registry | UK Registry | 750 | Ongoing | Know more | |||
| MILES Global Registry | Global Registry | 600 | Ongoing | Know more | |||
| BioMime Morph Sirolimus Eluting Coronary Stent System | |||||||
| Sponsor Initiated Studies | |||||||
| Morph India Study | Prospective study | 450 | Ongoing | Know more | |||
| Morpheus Global Registry | Global Registry | 400 | Ongoing | Know more | |||
| BioMime Morph BGM Study | Prospective study | 100 | Ongoing | Know more | |||
| Investigator Initiated Studies | |||||||
| BioMime Morph Multicenter study | Observational study | 362 | Completed | Know more | |||
| BioMime Morph study, Valencia, Spain | Investigator initiated study | 50 | Completed | Know more | |||
| BioMime Morph study, Russia | Investigator initiated study | 85 | Completed | Know more | |||
| BioMime Morph study, The Netherlands | Investigator initiated study | 49 | Completed | Know more | |||
| BioMime Morph study, Spain | Investigator initiated study | 628 | Completed | Know more | |||
| MeRes100 Bioresorbable Scaffold System | |||||||
| Sponsor Initiated Studies | |||||||
| MeRes-1 Study | First-in-man | 108 | Ongoing | Know more | |||
| MeRes-1 Extend Study | Global Study | 64 | Ongoing | Know more | |||
| Evermine 50 Everolimus Eluting Coronary Stent System | |||||||
| Sponsor Initiated Studies | |||||||
| Evermine 50 EES-1 Study | Prospective study | 140 | Ongoing | Know more | |||
| Evermine 50 EES- KLES Study | Observational study | 171 | Completed | Know more | |||
| Investigator Initiated Study | |||||||
| Evermine 50 EES- BGM Study | Investigator initiated study | 251 | Ongoing | Know more | |||
| Metafor Sirolimus Eluting Coronary Stent System | |||||||
| Investigator Initiated Studies | |||||||
| Metafor study, Hyderguda | Investigator initiated study | 127 | Completed | Know more | |||
| Metafor study, Hyderabad | Investigator initiated study | 251 | Completed | Know more | |||
| Obtura VCD | |||||||
| Sponsor Initiated Study | |||||||
| Obtura VCD-1 Study | Randomized controlled trial | 218 | Ongoing | Know more | |||
| MOZEC SEB PTCA Balloon Dilatation Catheter | |||||||
| Sponsor Initiated Study | |||||||
| MOZEC SEB PTCA-1 Study | Prospective study | 123 | Ongoing | Know more | |||
| CREDENCE BtK | |||||||
| Sponsor Initiated Study | |||||||
| CREDENCE BtK-1 Study | First-in-man | 30 | Ongoing | Know more | |||
| CREDENCE BRS | |||||||
| Sponsor Initiated Study | |||||||
| CREDENCE BRS-1 Study | First-in-man | 30 | Ongoing | Know more | |||
| MELANGE BRS | |||||||
| Sponsor Initiated Study | |||||||
| MELANGE BRS-1 Study | First-in-man | 45 | Ongoing | Know more | |||
| BioMime Branch | |||||||
| Sponsor Initiated Study | |||||||
| BioMime Branch-1 Study | Randomized controlled trial | 183 | Ongoing | Know more | |||
| Dafodil Pericardial Bioprosthesis | |||||||
| Dafodil-1 Study | First-in-man | 136 | Followup Ongoing | Know more | |||
| Myval TAVR | |||||||
| Sponsor Initiated Study | |||||||
| MyVal-1 Study | First-in-man | 30 | Ongoing | Know more | |||
| Promesa DES | |||||||
| Sponsor Initiated Study | |||||||
| Promesa DES-1 Study | First-in-man | 30 | Ongoing | Know more | |||
| PAXIMUS PEB PTA | |||||||
| Sponsor Initiated Study | |||||||
| PAXIMUS PEB PTA RCT-1 Study | Randomized controlled trial | 280 | Planned | Know more | |||
| Endo-surgery | |||||||
| MITSU Polyglactin 910 Suture | |||||||
| Sponsor Initiated Study | |||||||
| MITSU Polyglactin 910 Suture | Randomized controlled trial | 122 | Completed | Know more | |||
| MITSU AB Polyglactin 910 Suture | |||||||
| Sponsor Initiated Study | |||||||
| MITSU AB Polyglactin 910 Suture | Randomized controlled trial | 122 | Completed | Know more | |||
| MIRUS Disposable Hemorrhoids Stapler | |||||||
| Sponsor Initiated Study | |||||||
| MIRUS Disposable Hemorrhoids Stapler | Prospective study | 82 | Completed | Know more | |||
| Investigator Initiated study | |||||||
| MIRUS Stapler, Ranchi | Retrospective study | 150 | Completed | Know more | |||
| Fiona IUD | |||||||
| Sponsor Initiated Study | |||||||
| Fiona-1 | Prospective study | 309 | Ongoing | Know more | |||
| MERIZELLE ORC U.S.P | |||||||
| Sponsor Initiated Study | |||||||
| MERIZELLE-1 | Prospective study | 185 | Ongoing | Know more | |||
| Diagnostic | |||||||
| EXIMO Blood Glucose Monitoring System | |||||||
| Sponsor Initiated Study | |||||||
| EXIMO | Prospective study | 1005 | Completed | Know more | |||
| Orthopedic | |||||||
| Latitud Hip Replacement System | |||||||
| Sponsor Initiated Study | |||||||
| Latitud 180 study | Prospective study | 180 | Ongoing | Know more | |||
| PEEK-OPTIMA femoral component | |||||||
| Sponsor Initiated Study | |||||||
| PEEK India | First-in-man | 34 | Planned | Know more | |||
| ETERNAL Total Knee Replacement System | |||||||
| Sponsor Initiated Study | |||||||
| ETERNAL-1 study | First-in-man | 60 | Planned | Know more | |||
| Freedom Total Knee System | |||||||
| Sponsor Initiated Study | |||||||
| Freedom 400 study | Prospective study | 400 | Ongoing | Know more | |||
| Freedom 450 study, UK | Prospective study | 450 | Planned | Know more | |||
| Investigator Initiated Study | |||||||
| Freedom study, Amritsar, India | Investigator initiated study | 158 | Completed | Know more | |||
Meriscreen COVID-19 Antigen Reports:
1. Analytical Sensitivity - Limit of Detection: Click here
2. Analytical Specificity - Interference Study: Click here
3. Measuring range of Assay - Hook effect Report: Click here
4. Repeatability and Reproducibility Study Report: Click here
5. Specimen Stability Study Report: Click here
6. Clinical Evaluation Report - MERISCREEN COVID-19 Antigen Detection Test: Click here